QURE- Uniqure N.V.

Name: Uniqure N.V. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Uniqure N.V. (QURE) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. QURE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kapusta Matthew C	826.5K	$37.70M	-
Other	Abi-Saab Walid	150.4K	$6.86M	-
Other	Potts Jeannette	133.2K	$6.08M	-5,237
Other	O'Keefe Kylie	124.8K	$5.69M	-
CFO	Klemt Christian	63.9K	$2.92M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 15, 2026	Potts Jeannette	Chief Legal Officer	Sell	5,237	$27.67	$144,907.79	-3.8%	-	-
Jun 15, 2026	Balachandran Madhavan52	Director	Sale+OE	10,000	$27.85	$278,500.00	-18.8%	-	-
Jun 11, 2026	Meek David D.51	Director	Sell	1,993	$27.06	$53,930.58	-4.8%	-	-
Jun 3, 2026	Kaye Jack53	Director	Sale+OE	2,645	$30.01	$79,376.45	-11.5%	-	-
Mar 4, 2026	Klemt Christian58	Chief Financial Officer	Sell	12,000	$9.06	$108,720.00	-5.0%	+195.4%	-
Mar 2, 2026	Potts Jeannette	Chief Legal Officer	Sell	8,578	$9.95	$85,351.10	-7.5%	+172.1%	-
Mar 2, 2026	Klemt Christian58	Chief Financial Officer	Sell	12,532	$9.95	$124,693.40	-5.9%	+172.1%	-
Jan 12, 2026	Gut Robert69	Director	Sale+OE	25,613	$24.62	$630,483.17	-18.5%	-33.2%	-
Jan 9, 2026	Kaye Jack53	Director	Sale+OE	6,390	$27.28	$174,319.20	-23.8%	-35.6%	-
Nov 6, 2025	Gut Robert69	Director	Sale+OE	31,434	$27.26	$856,881.00	-24.7%	-3.1%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC